文献速递临床试验与 GCP

食管切除术后胃 remnant 重建中幽门成形术与不干预对比:PYNI-GAREREO III期随机对照试验研究方案

PYloroplasty versus No Intervention in GAstric REmnant REconstruction after Oesophagectomy: study protocol for the PYNI-GAREREO phase III randomized controlled trial.
PubMed 文献 · Trials · 2023-06-19

PYNI-GAREREO 是一项开放、单中心、优效性 III 期随机对照试验,计划纳入 140 例拟行治愈性微创食管切除术的食管癌或食管胃交界癌患者,按 1:1 随机分配至改良 Horsley 幽门成形术(mH-P)组或无干预对照组。主要结局为术后 6 个月体重变化,次要结局包括营养状态、术后并发症、功能结局及术后 1 年内生活质量。研究假设 mH-P 较不进行幽门成形术能更有效维持患者营养状态。

要点

  • 食管切除术后超过半数患者 12 个月时体重下降超过 10%。
  • 胃 remnant 重建后延迟胃排空是严重营养并发症,与胃 remnant 游离及迷走神经去神经支配有关。
  • 本研究为开放、单中心、优效性 III 期随机对照试验,计划纳入 140 例,1:1 随机分组。

核心结论

  • 研究假设微创食管切除术后行 mH-P 较不进行幽门成形术能更有效维持患者营养状态。

研究设计与样本

  • PYNI-GAREREO 为开放、单中心、优效性 III 期随机对照试验,平行分组。
  • 计划纳入 140 例拟行治愈性微创食管切除术的食管癌或食管胃交界癌患者,按 1:1 随机分配至 mH-P 组或无干预对照组。

主要发现

  • 主要结局为术后 6 个月体重变化。
  • 次要结局包括营养状态、术后并发症、功能结局及术后 1 年内生活质量。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: After esophagectomy for esophageal and esophagogastric cancer, more than half of patients have lost > 10% of their body weight at 12 months. In most cases, the gastric remnant is used for reconstruction after esophagectomy. One of the most serious nutritional complications of this technique is delayed gastric emptying caused by gastric remnant mobilization and denervation of the vagus nerve. The aim of the PYloroplasty versus No Intervention in GAstric REmnant REconstruction after Oesophagectomy (PYNI-GAREREO) trial is to analyze the clinical outcome of modified Horsley pyloroplasty (mH-P) as a method of preventing delayed gastric emptying. METHODS: The PYNI-GAREREO trial is designed as an open randomized, single-center superiority trial. Patients will be randomly allocated to undergo gastric remnant reconstruction with mH-P (intervention group) or no intervention (control group) in parallel groups. All patients with esophageal cancer or esophagogastric cancer planning to undergo curative minimally invasive esophagectomy will be considered for inclusion. A total of 140 patients will be included in the study and randomized between the groups in a 1:1 ratio. The primary outcome is the body weight change at 6 months postoperatively, and the secondary outcomes are the nutritional status, postoperative complications, functional outcome, and quality of life until 1 year postoperatively. DISCUSSION: We hypothesize that mH-P after minimally invasive esophagectomy more effectively maintains patients' nutritional status than no pyloroplasty. TRIAL REGISTRATION: UMIN Clinical Trials Registry UMIN000045104. Registered on 25 August 2021. https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000051346 .

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Okada N, Kinoshita Y, Nishihara S, et al. PYloroplasty versus No Intervention in GAstric REmnant REconstruction after Oesophagectomy: study protocol for the PYNI-GAREREO phase III randomized controlled trial. Trials. 2023. PMID: 37337238. doi:10.1186/s13063-023-07435-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。